Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Kavanaugh

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Immunology|November 1, 1996
Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis after treatment with a monoclonal antibody to CD54 (ICAM-1)H Schulze-Koops, P E Lipsky, A F Kavanaugh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritisL S Davis, A F Kavanaugh, L A Nichols, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1995
Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefitH Schulze-Koops, P E Lipsky, A F Kavanaugh, et al.
The Journal of Allergy and Clinical Immunology|January 1, 1991
Immunoglobulin deficiency syndromes and therapyD P Huston, A F Kavanaugh, P W Rohane, et al.
Arthritis and Rheumatism|May 1, 1997
Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibodyA F Kavanaugh, H Schulze-Koops, L S Davis, et al.
Arthritis and Rheumatism|April 1, 1997
Elevated cytokine messenger RNA levels in the peripheral blood of patients with rheumatoid arthritis suggest different degrees of myeloid cell activationH Schulze-Koops, L S Davis, A F Kavanaugh, et al.
The American Journal of Medicine|February 1, 1987
Cyclosporine therapy of central nervous system sarcoidosisA F Kavanaugh, S L Andrew, B Cooper, et al.
The American Journal of Medicine|February 10, 1998
An evidence-based medicine approach to the diagnosis and management of musculoskeletal complaintsA G Ellrodt, M Cho, J J Cush, et al.
The Journal of Rheumatology|October 1, 1992
Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agentsS Vasquez, A F Kavanaugh, N R Schneider, et al.
Annals of the Rheumatic Diseases|November 26, 2005
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended studyM E Weinblatt, E C Keystone, D E Furst, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Immunology|November 1, 1996
Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis after treatment with a monoclonal antibody to CD54 (ICAM-1)H Schulze-Koops, P E Lipsky, A F Kavanaugh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritisL S Davis, A F Kavanaugh, L A Nichols, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1995
Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefitH Schulze-Koops, P E Lipsky, A F Kavanaugh, et al.
The Journal of Allergy and Clinical Immunology|January 1, 1991
Immunoglobulin deficiency syndromes and therapyD P Huston, A F Kavanaugh, P W Rohane, et al.
Arthritis and Rheumatism|May 1, 1997
Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibodyA F Kavanaugh, H Schulze-Koops, L S Davis, et al.
Arthritis and Rheumatism|April 1, 1997
Elevated cytokine messenger RNA levels in the peripheral blood of patients with rheumatoid arthritis suggest different degrees of myeloid cell activationH Schulze-Koops, L S Davis, A F Kavanaugh, et al.
The American Journal of Medicine|February 1, 1987
Cyclosporine therapy of central nervous system sarcoidosisA F Kavanaugh, S L Andrew, B Cooper, et al.
The American Journal of Medicine|February 10, 1998
An evidence-based medicine approach to the diagnosis and management of musculoskeletal complaintsA G Ellrodt, M Cho, J J Cush, et al.
The Journal of Rheumatology|October 1, 1992
Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agentsS Vasquez, A F Kavanaugh, N R Schneider, et al.
Annals of the Rheumatic Diseases|November 26, 2005
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended studyM E Weinblatt, E C Keystone, D E Furst, et al.
Pageof 3